Perbedaan Bank Permata Tbk dan Brigit Biofarmaka Teknologi Tbk.: Bank Permata Tbk diperdagangkan di Rp2.330 (kapitalisasi pasar 83,46 T, volume 24 jam 45,6 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Bank Permata Tbk jauh lebih besar — sekitar 498,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (71 rb vs 45,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BNLI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 83,46 T | 167,37 M |
Volume | 45,6 rb | 71 rb |
Lot | 456 | 710 |
Perputaran | 106,92 jt | 17,51 jt |
Harga Rata-rata | 2.344,82 | 246,63 |
Nilai Transaksi | 106,92 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 2.330 | 246 |
Volume Ekuilibrium Indikatif | 31 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bank Permata Tbk (formerly PT Bank Bali) was established in Indonesia on December 17, 1954, under the name of Bank Persatuan Dagang Indonesia, the bank changed to its present name in 1971. Bank Bali is Indonesia`s eighth largest private national. The majority of its clients are medium sized institutions.
Selengkapnya di halaman BNLI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →